Fasting plasma insulin modulates lipid levels and particle sizes in 2- to 3-year-old children.
about
A novel approach to the study of pediatric obesity: a biomarker model.Lipoprotein particle concentrations in children and adults following Kawasaki disease.The effect of insulin resistance and obesity on low-density lipoprotein particle size in childrenAdiposity is associated with endothelial activation in healthy 2-3 year-old children.High density lipoprotein particle size in children: relation to atherogenic dyslipidemia.Pediatric reference intervals: challenges and recent initiatives.
P2860
Fasting plasma insulin modulates lipid levels and particle sizes in 2- to 3-year-old children.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Fasting plasma insulin modulat ...... in 2- to 3-year-old children.
@en
Fasting plasma insulin modulat ...... in 2- to 3-year-old children.
@nl
type
label
Fasting plasma insulin modulat ...... in 2- to 3-year-old children.
@en
Fasting plasma insulin modulat ...... in 2- to 3-year-old children.
@nl
prefLabel
Fasting plasma insulin modulat ...... in 2- to 3-year-old children.
@en
Fasting plasma insulin modulat ...... in 2- to 3-year-old children.
@nl
P2093
P2860
P356
P1433
P1476
Fasting plasma insulin modulat ...... in 2- to 3-year-old children.
@en
P2093
Eve Aymong
Harry Shamoon
Patricia Zybert
Richard J Deckelbaum
Steven Shea
P2860
P304
P356
10.1038/OBY.2003.101
P577
2003-06-01T00:00:00Z